Pfizer begins tender for $3.25 billion of 6.2% senior notes due 2019

By Susanna Moon

Chicago, Nov. 14 – Pfizer Inc. said it began a cash tender offer for its $3.25 billion of outstanding 6.2% senior notes due March 15, 2019.

Pricing will be set at 2 p.m. ET on Nov. 18 using the 1% U.S. Treasury notes due Nov. 15, 2019 plus 25 basis points for a hypothetical purchase price of $1,109.23 for each $1,000 principal amount.

The hypothetical purchase price was set at 2 p.m. ET on Nov. 10 with a settlement date of Nov. 21.

Holders will also receive accrued interest up to but excluding the payment date of Nov. 21.

The tender offer will end at 5 p.m. ET on Nov. 18.

Pfizer plans to issue a make-whole call for any notes remaining after the tender offer, according to a company announcement.

Citigroup Global Markets Inc. (800 558-3745 or 212 723-6106) is the dealer manager. Global Bondholder Services Corp. (866 470-4300 or 212 430-3774) is the depositary and information agent.

Pfizer is a biopharmaceutical company based in New York.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.